IMMUNITYBIO, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -41.2% | -41.2% | -38.1% |
| FY2017 | -44.1% | -44.1% | -38.5% |
| FY2018 | -65.9% | -65.9% | -52.9% |
| FY2019 | -130.7% | -130.7% | -110.2% |
| FY2020 | 185.2% | 185.2% | -100.2% |
| FY2021 | 143.2% | 143.2% | -74.0% |
| FY2022 | 93.1% | 93.1% | -115.0% |
| FY2023 | 99.4% | 99.4% | -115.6% |
| FY2024 | 84.6% | 84.6% | -108.0% |
| FY2025 | 70.2% | 70.2% | -70.0% |